Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur Ann Allergy Clin Immunol ; 40(3): 77-83, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19334371

RESUMO

BACKGROUND: The natural history of respiratory allergy is commonly characterized by a worsening of symptom severity, frequent comorbidity of rhinitis and asthma, and polysensitization to aeroallergens. The polysensitization phenomenon starts since childhood and is rare to find monosensitized adult patients. However, there are few studies investigating the characteristics of polysensitized patients. METHODS: This study was performed on a large cohort of patients with allergic rhinitis (assessed by ARIA criteria) and/or mild to moderate asthma (assessed by GINA). The kind and the number of sensitizations, their patterns, and the relation with quality of life (QoL) measured by the Juniper's RQLQ guestionnaire, were evaluated. RESULTS: Globally 418 patients (50.2% males, 49.8% females, mean age 26.4 years, range 3.5-65 years, 64 smokers, 371 non-smokers) were enrolled: 220 had allergic rhinitis alone, and 198 allergic rhinitis and asthma. The mean number ofsensitizations was 2.6. Three hundred-five patients (73%) had persistent rhinitis (PER), 220 of them with moderate-severe form. There was no significant derence in rate of rhinitis and asthma in monosensitized or polysensitized patients. Most patients were sensitized to pollens, whereas only 24.2% of them were sensitized to perennial allergens. Polysensitization was significantly associated with some issues of QoL, confirming previous findings, but not with number ofsensitizations. CONCLUSIONS: This study provides data confirming for poly-sensitized patients the relevance of ARIA classification of AR. PER is the most common form of AR in this cohort, symptoms are frequently moderate-severe, and asthma is present in about the half of patients with AR.


Assuntos
Alérgenos/efeitos adversos , Adolescente , Adulto , Fatores Etários , Idoso , Animais , Antialérgicos/uso terapêutico , Antígenos de Plantas/efeitos adversos , Asma/tratamento farmacológico , Asma/epidemiologia , Asma/etiologia , Gatos , Criança , Pré-Escolar , Estudos de Coortes , Cães , Feminino , Fungos , Humanos , Imunização , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Pólen/efeitos adversos , Estudos Prospectivos , Pyroglyphidae , Qualidade de Vida , Rinite Alérgica Perene/tratamento farmacológico , Rinite Alérgica Perene/epidemiologia , Rinite Alérgica Perene/etiologia , Rinite Alérgica Sazonal/tratamento farmacológico , Rinite Alérgica Sazonal/epidemiologia , Rinite Alérgica Sazonal/etiologia , Testes Cutâneos , Fumar/epidemiologia , Adulto Jovem
2.
Minerva Pediatr ; 55(5): 447-52, 2003 Oct.
Artigo em Italiano | MEDLINE | ID: mdl-14608267

RESUMO

AIM: The aim of this paper is to determine the efficacy of a fructo-oligosaccharides (FOS)-Lactobacillus sporogenes preparation in the prevention of diarrhea due to antibiotics in childhood. METHODS: A multicentre, randomised, double-blind versus placebo study was carried out. A total of 120 children, with active infections requiring antibiotics, were enrolled in the study and treated for 10 days either in the experimental group (F) or in the placebo one (P). The results of the study were recorded from the patients' diary and from follow-up clinical examinations. RESULTS: Out of 98 evaluable patients, 71% in group F had no diarrhea versus 38% in group P. The duration of diarrhea in F and P groups was 0.7 vs 1.6 days (p=0.002), respectively. CONCLUSION: Prophylaxis with Lactobacillus sporogens, associated to FOS, significantly reduced the number of days and duration of events in children with antibiotic-induced diarrhea.


Assuntos
Antibacterianos/efeitos adversos , Diarreia/prevenção & controle , Lactobacillus , Oligossacarídeos/uso terapêutico , Probióticos , Adolescente , Criança , Pré-Escolar , Interpretação Estatística de Dados , Diarreia/induzido quimicamente , Método Duplo-Cego , Feminino , Humanos , Lactente , Masculino , Placebos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA